4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-26-034675
CEO and CFO bought 3,600 shares at an average $13.06 ($47,018)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2026-07-23 | Purchase | +2,500 | $13.14 | $32,850 | 5,606,602 | D |
| Patel Snehal CEO and CFO | 2026-07-24 | Purchase | +1,100 | $12.88 | $14,168 | 5,607,702 | D |
| Open-market purchases · 3,600 sh · avg $13.06 · $47,018 | |||||||
Loading xslF345X06/ownership.xml…